{"gene":"SLC6A4","run_date":"2026-06-10T07:46:34","timeline":{"discoveries":[{"year":1996,"finding":"The rat serotonin transporter SERT1 (SLC6A4 ortholog) forms oligomeric complexes at the membrane. Treatment of recombinantly expressed SERT1 in HEK293 cells with sulfhydryl oxidizing agents and the cross-linker dimethyl suberimidate (DMS) generated adducts of 130–180 kDa and 220–270 kDa, indicating an oligomeric (likely dimeric/tetrameric) quaternary structure.","method":"Chemical cross-linking (DMS), sulfhydryl oxidation, SDS-PAGE of recombinantly expressed SERT1 in HEK293 cells","journal":"FEBS letters","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — in vitro biochemical reconstitution with cross-linking in a single study; no mutagenesis or structural validation to define interface","pmids":["8925924"],"is_preprint":false},{"year":2003,"finding":"Glucocorticoid (dexamethasone) administration increases SLC6A4 (5-HTT) expression in a genotype-dependent manner in human B-lymphoblastoid cells. Reporter gene assays, 5-HT uptake, and inhibitor binding measures showed a dose-response to dexamethasone that was antagonized by RU 38486, and depended on a repetitive GC-rich sequence ~1.4 kb upstream of the transcription start site (within the 5-HTTLPR region), as deletion of this sequence abolished the steroid effect.","method":"Reporter gene (luciferase) assays, 5-HT uptake assay, radioligand binding, deletional mutagenesis of promoter constructs, pharmacological antagonism (RU 38486) in human lymphoblastoid cells","journal":"Journal of neurochemistry","confidence":"High","confidence_rationale":"Tier 1 / Moderate — multiple orthogonal methods (reporter assay, uptake, binding, deletional mutagenesis, pharmacological rescue) in a single well-controlled study","pmids":["12911615"],"is_preprint":false},{"year":2011,"finding":"Berberine and evodiamine increase SLC6A4 (5-HTT) mRNA and protein expression, and increase 5-HTT promoter activity in a serotonergic neuronal cell line (RN46A). The magnitude of the promoter activity increase was allele-specific across S, XS, LG, LA, XL17, and XL18 variants of the 5-HTTLPR, demonstrating that the 5-HTTLPR polymorphism modulates the transcriptional response to these compounds.","method":"RT-PCR (mRNA), Western blot (protein), luciferase reporter assays across multiple allelic variants in RN46A cells","journal":"The pharmacogenomics journal","confidence":"Medium","confidence_rationale":"Tier 1 / Weak — multiple methods (mRNA, protein, reporter) in a single lab; no in vivo validation or independent replication","pmids":["21647174"],"is_preprint":false},{"year":2019,"finding":"Fluoxetine activates BDNF/TrkB signaling and promotes neuroplasticity through a 5-HTT-independent mechanism. In primary cortical neurons from 5-Htt knockout mice, fluoxetine (10 µM) still activated BDNF/TrkB pathways and increased plasticity gene expression, demonstrating that 5-HTT blockade is not required for these neuroplastic effects of fluoxetine.","method":"Western blotting, RT-qPCR in primary cortical neurons from 5-Htt wild-type and knockout mice; in vivo treatment (15 mg/kg/day i.p.) with assessment of hippocampal cell proliferation","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean genetic KO model with multiple molecular readouts (protein, mRNA, proliferation); single lab but orthogonal methods","pmids":["31004120"],"is_preprint":false},{"year":2011,"finding":"Loss of 5-HTT (SLC6A4) in mice impairs extinction recall of conditioned fear and is accompanied by increased theta synchronization between the lateral amygdala and infralimbic prefrontal cortex during extinction learning, establishing a role for 5-HTT in amygdala-prefrontal circuit function underlying fear extinction.","method":"Pavlovian fear conditioning, in vivo electrophysiology (simultaneous recording in lateral amygdala and mPFC), behavioral testing in 5-HTT knockout (-/-), heterozygous (+/-), and wild-type (+/+) mice","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — clean genetic KO with paired behavioral and neurophysiological readouts; single lab, multiple orthogonal measures","pmids":["21818344"],"is_preprint":false},{"year":2014,"finding":"5-HTT deficiency in mice increases hippocampal adult neurogenesis (elevated Ki67+ and NeuroD+ cell counts) and immediate early gene expression (cFos, Arc), and heightens corticosterone responses to spatial learning tasks, establishing that SLC6A4 regulates hippocampal neuroplasticity and stress reactivity in vivo.","method":"Quantitative immunohistochemistry (Ki67, NeuroD, cFos, Arc), plasma corticosterone measurement, Morris water maze and Barnes maze behavioral testing in 5-HTT knockout and wild-type mice","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with multiple cellular and behavioral readouts; single lab study","pmids":["24167611"],"is_preprint":false},{"year":2014,"finding":"5-HT2C receptor responsiveness is blunted in 5-HTT-deficient mice: 5-HTT(-/-) mice show reduced 5-HT2CR-mediated anxiety behavior and attenuated 5-HT2CR-mediated inhibition of stress-induced 5-HT turnover, without changes in 5-HT2CR protein, mRNA levels, or pre-mRNA editing. However, basal c-fos mRNA in 5-HT2CR-expressing cortical cells was elevated in knockouts, indicating altered basal cellular activity downstream of chronic 5-HT reuptake inactivation.","method":"Behavioral tests (social interaction, novelty-suppressed feeding, hypolocomotion), neurochemical assays (5-HT turnover), RT-qPCR, mRNA editing analysis, c-fos immunohistochemistry in 5-HTT(-/-) mice","journal":"The international journal of neuropsychopharmacology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic KO with multiple orthogonal readouts (behavioral, neurochemical, molecular); single lab","pmids":["25522398"],"is_preprint":false},{"year":2022,"finding":"In non-small cell lung cancer (NSCLC) cells, 5-HT promotes SLC6A4 expression via a c-Myc/TRIB3-dependent signaling loop: 5-HT activates TRIB3, which stimulates c-Myc transcriptional activity, and c-Myc upregulates SLC6A4 expression, thereby enhancing 5-HT uptake into tumor cells and creating a positive feedback loop that promotes tumorigenicity and metastasis.","method":"Western blotting, immunofluorescence, colony-formation assay, Transwell migration/invasion assay, immunohistochemistry in NSCLC patient tissues and A549 cells; in vivo xenograft model with 5-HT uptake inhibitor","journal":"Biochimica et biophysica acta. General subjects","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — multiple orthogonal methods (molecular, cellular, in vivo) identifying a mechanistic loop; single lab study","pmids":["35066124"],"is_preprint":false},{"year":2017,"finding":"DNA methylation of the SLC6A4 distal promoter region inversely correlates with SLC6A4 mRNA expression in human placenta, and gestational diabetes mellitus decreases average methylation at this region, suggesting epigenetic regulation of placental SLC6A4 expression by maternal metabolic state. No significant association was found between SLC6A4 genotype (5-HTTLPR, STin2, rs25531) and placental mRNA levels, indicating a predominant epigenetic over genetic regulation of expression in this tissue.","method":"Bisulfite sequencing (quantitative CpG methylation at 7 sites), RT-qPCR (mRNA expression), PCR-based genotyping in human placental tissue from 50 mother-infant pairs","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct methylation-expression correlation in human tissue with orthogonal methods; single study, modest sample size","pmids":["28650965"],"is_preprint":false},{"year":2010,"finding":"PET imaging with [11C]DASB in 63 healthy volunteers showed that 5-HTTLPR polymorphic variation (biallelic S/L or triallelic LA/LG/S classification) does not significantly affect 5-HTT binding potential in any of seven brain regions in vivo, suggesting that reported effects of 5-HTTLPR on emotion and depression risk are more likely mediated through neurodevelopmental effects rather than adult transporter density differences.","method":"Positron emission tomography (PET) with [11C]DASB radioligand, binding potential quantification in seven brain regions, genotyping for 5-HTTLPR and rs25531","journal":"NeuroImage","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — rigorous PET imaging in a relatively large sample (n=63) with optimal radiotracer; single study but well-controlled negative finding","pmids":["20406689"],"is_preprint":false}],"current_model":"SLC6A4 encodes the serotonin transporter (SERT/5-HTT), a sodium-dependent membrane protein that reuptakes serotonin from the synapse into presynaptic neurons; it forms oligomeric complexes, its transcription is upregulated by glucocorticoids through a GC-rich upstream element in an allele-specific manner, its promoter is subject to DNA methylation that inversely correlates with expression, it regulates hippocampal neuroplasticity and amygdala-prefrontal circuit function underlying fear extinction, modulates 5-HT2C receptor responsiveness through chronic serotonin exposure, and in cancer cells participates in a c-Myc/TRIB3-driven positive feedback loop that promotes 5-HT uptake and tumor progression."},"narrative":{"mechanistic_narrative":"SLC6A4 encodes the serotonin transporter (SERT/5-HTT), a sodium-dependent membrane transporter that clears serotonin (5-HT) from the extracellular space and assembles into oligomeric (dimeric/tetrameric) complexes at the membrane [PMID:8925924, PMID:35066124]. Its transcription is under combined hormonal and epigenetic control: glucocorticoids upregulate expression through a GC-rich element ~1.4 kb upstream of the start site within the 5-HTTLPR region in a genotype-dependent, RU 38486–reversible manner [PMID:12911615], small-molecule inducers (berberine, evodiamine) drive promoter activity in an allele-specific fashion across 5-HTTLPR variants [PMID:21647174], and DNA methylation of the distal promoter inversely tracks with mRNA levels in human tissue [PMID:28650965]. In vivo, loss of 5-HTT shapes neural circuit function and plasticity: knockout mice show impaired fear extinction recall with altered amygdala–prefrontal theta synchronization [PMID:21818344], increased hippocampal adult neurogenesis and immediate-early gene expression with heightened corticosterone stress responses [PMID:24167611], and blunted 5-HT2C receptor–mediated behavioral and neurochemical responses downstream of chronic loss of 5-HT reuptake [PMID:25522398]. Beyond the nervous system, SLC6A4 participates in a c-Myc/TRIB3-driven positive feedback loop in non-small cell lung cancer in which 5-HT induces its own transporter, enhancing 5-HT uptake to promote tumorigenicity and metastasis [PMID:35066124]. Notably, some neuroplastic effects of fluoxetine occur independently of 5-HTT, as fluoxetine still activates BDNF/TrkB signaling in 5-HTT-knockout neurons [PMID:31004120].","teleology":[{"year":1996,"claim":"Established that SERT is not an isolated monomer but assembles into higher-order oligomers at the membrane, defining its quaternary structure.","evidence":"Chemical cross-linking (DMS) and sulfhydryl oxidation of recombinant rat SERT1 in HEK293 cells resolved by SDS-PAGE","pmids":["8925924"],"confidence":"Medium","gaps":["No mutagenesis or structural data defining the oligomerization interface","Functional consequence of oligomerization for transport not addressed","Demonstrated for rat ortholog in heterologous cells only"]},{"year":2003,"claim":"Resolved how stress hormones control transporter abundance, showing glucocorticoid induction of SLC6A4 operates through a defined upstream GC-rich element in a genotype-dependent way.","evidence":"Reporter assays, 5-HT uptake, radioligand binding, promoter deletional mutagenesis and RU 38486 antagonism in human lymphoblastoid cells","pmids":["12911615"],"confidence":"High","gaps":["Whether the same element governs glucocorticoid regulation in neurons not tested","Direct receptor binding to the element not demonstrated"]},{"year":2010,"claim":"Tested whether the 5-HTTLPR genotype alters transporter density in the living human brain, and found no significant effect, redirecting interpretation toward neurodevelopmental rather than adult-density mechanisms.","evidence":"PET with [11C]DASB binding potential across seven brain regions in 63 genotyped healthy volunteers","pmids":["20406689"],"confidence":"Medium","gaps":["Negative finding in adults does not exclude developmental or regional micro-scale effects","Does not address functional (uptake kinetics) differences independent of density"]},{"year":2011,"claim":"Connected 5-HTT loss to a specific behavioral circuit, showing it is required for fear extinction recall and normal amygdala-prefrontal oscillatory coupling.","evidence":"Pavlovian fear conditioning with paired in vivo electrophysiology in 5-HTT knockout, heterozygous, and wild-type mice","pmids":["21818344"],"confidence":"Medium","gaps":["Developmental vs acute contribution of 5-HTT loss not separated","Cell-type and circuit-specific mediators of theta change unresolved"]},{"year":2011,"claim":"Showed that the transcriptional response of SLC6A4 to pharmacological inducers is shaped by 5-HTTLPR allelic identity, extending allele-specific regulation beyond glucocorticoids.","evidence":"RT-PCR, Western blot, and luciferase reporter assays across S, XS, LG, LA, XL17, XL18 variants in RN46A serotonergic cells","pmids":["21647174"],"confidence":"Medium","gaps":["No in vivo validation","Mechanism linking compounds to promoter not defined","Not independently replicated"]},{"year":2014,"claim":"Demonstrated that chronic loss of reuptake reshapes hippocampal plasticity and stress reactivity, establishing a role for SLC6A4 in neurogenesis and corticosterone responses.","evidence":"Quantitative immunohistochemistry (Ki67, NeuroD, cFos, Arc), plasma corticosterone, and maze behavioral testing in 5-HTT knockout mice","pmids":["24167611"],"confidence":"Medium","gaps":["Whether plasticity changes are cause or consequence of altered behavior unclear","Single-lab study"]},{"year":2014,"claim":"Identified a downstream consequence of chronic reuptake loss on receptor signaling, showing blunted 5-HT2C receptor responsiveness without changes in receptor expression or editing.","evidence":"Behavioral, neurochemical (5-HT turnover), RT-qPCR, mRNA editing, and c-fos IHC analyses in 5-HTT knockout mice","pmids":["25522398"],"confidence":"Medium","gaps":["Mechanism of functional 5-HT2C desensitization not defined","Elevated basal c-fos not mechanistically explained"]},{"year":2017,"claim":"Established epigenetic control of SLC6A4 expression in a peripheral tissue, showing distal-promoter methylation inversely tracks mRNA and is modulated by maternal metabolic state.","evidence":"Bisulfite sequencing, RT-qPCR, and genotyping in human placenta from 50 mother-infant pairs","pmids":["28650965"],"confidence":"Medium","gaps":["Causality of methylation on expression not demonstrated","Modest sample size","Tissue-specificity vs neuronal regulation unaddressed"]},{"year":2019,"claim":"Dissociated fluoxetine's neuroplastic action from its target, showing BDNF/TrkB activation persists without 5-HTT.","evidence":"Western blotting and RT-qPCR in primary cortical neurons from 5-Htt knockout and wild-type mice, with in vivo proliferation assessment","pmids":["31004120"],"confidence":"Medium","gaps":["Alternative direct fluoxetine target not identified","Relevance to therapeutic antidepressant action not established"]},{"year":2022,"claim":"Extended SLC6A4 function beyond neurons, defining a c-Myc/TRIB3 positive feedback loop in which 5-HT induces its own transporter to drive tumor progression.","evidence":"Western blot, immunofluorescence, colony-formation, migration/invasion assays, patient IHC, and xenograft with uptake inhibitor in NSCLC cells","pmids":["35066124"],"confidence":"Medium","gaps":["Direct c-Myc binding to the SLC6A4 promoter not shown","Generalizability to other tumor types untested"]},{"year":null,"claim":"How transporter oligomerization, allele- and methylation-dependent transcriptional control, and circuit-level neuroplasticity phenotypes mechanistically interconnect remains unresolved.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No structural model linking oligomerization to transport function in the captured corpus","Causal chain from transcriptional/epigenetic regulation to in vivo behavioral phenotypes not established"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0005215","term_label":"transporter activity","supporting_discovery_ids":[1,7]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[0]}],"pathway":[],"complexes":[],"partners":[],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"P31645","full_name":"Sodium-dependent serotonin transporter","aliases":["5HT transporter","5HTT","Solute carrier family 6 member 4"],"length_aa":630,"mass_kda":70.3,"function":"Serotonin transporter that cotransports serotonin with one Na(+) ion in exchange for one K(+) ion and possibly one proton in an overall electroneutral transport cycle. Transports serotonin across the plasma membrane from the extracellular compartment to the cytosol thus limiting serotonin intercellular signaling (PubMed:10407194, PubMed:12869649, PubMed:21730057, PubMed:27049939, PubMed:27756841, PubMed:34851672). Essential for serotonin homeostasis in the central nervous system. In the developing somatosensory cortex, acts in glutamatergic neurons to control serotonin uptake and its trophic functions accounting for proper spatial organization of cortical neurons and elaboration of sensory circuits. In the mature cortex, acts primarily in brainstem raphe neurons to mediate serotonin uptake from the synaptic cleft back into the pre-synaptic terminal thus terminating serotonin signaling at the synapse (By similarity). Modulates mucosal serotonin levels in the gastrointestinal tract through uptake and clearance of serotonin in enterocytes. Required for enteric neurogenesis and gastrointestinal reflexes (By similarity). Regulates blood serotonin levels by ensuring rapid high affinity uptake of serotonin from plasma to platelets, where it is further stored in dense granules via vesicular monoamine transporters and then released upon stimulation (PubMed:17506858, PubMed:18317590). Mechanistically, the transport cycle starts with an outward-open conformation having Na1(+) and Cl(-) sites occupied. The binding of a second extracellular Na2(+) ion and serotonin substrate leads to structural changes to outward-occluded to inward-occluded to inward-open, where the Na2(+) ion and serotonin are released into the cytosol. Binding of intracellular K(+) ion induces conformational transitions to inward-occluded to outward-open and completes the cycle by releasing K(+) possibly together with a proton bound to Asp-98 into the extracellular compartment. Na1(+) and Cl(-) ions remain bound throughout the transport cycle (PubMed:10407194, PubMed:12869649, PubMed:21730057, PubMed:27049939, PubMed:27756841, PubMed:34851672). Additionally, displays serotonin-induced channel-like conductance for monovalent cations, mainly Na(+) ions. The channel activity is uncoupled from the transport cycle and may contribute to the membrane resting potential or excitability (By similarity)","subcellular_location":"Cell membrane; Endomembrane system; Endosome membrane; Synapse; Cell junction, focal adhesion; Cell projection, neuron projection","url":"https://www.uniprot.org/uniprotkb/P31645/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/SLC6A4","classification":"Not Classified","n_dependent_lines":6,"n_total_lines":1208,"dependency_fraction":0.004966887417218543},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/SLC6A4","total_profiled":1310},"omim":[{"mim_id":"617503","title":"DENN DOMAIN-CONTAINING PROTEIN 3; DENND3","url":"https://www.omim.org/entry/617503"},{"mim_id":"616448","title":"RAS-ASSOCIATED PROTEIN RAB12; RAB12","url":"https://www.omim.org/entry/616448"},{"mim_id":"616417","title":"ADHESION G PROTEIN-COUPLED RECEPTOR L3; ADGRL3","url":"https://www.omim.org/entry/616417"},{"mim_id":"613675","title":"CHROMOSOME 17q11.2 DELETION SYNDROME, 1.4-MB","url":"https://www.omim.org/entry/613675"},{"mim_id":"612276","title":"YRDC DOMAIN-CONTAINING PROTEIN; YRDC","url":"https://www.omim.org/entry/612276"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Golgi apparatus","reliability":"Supported"},{"location":"Vesicles","reliability":"Supported"}],"tissue_specificity":"Group enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"intestine","ntpm":38.0},{"tissue":"lung","ntpm":27.2},{"tissue":"placenta","ntpm":17.3}],"url":"https://www.proteinatlas.org/search/SLC6A4"},"hgnc":{"alias_symbol":["5-HTT","SERT1"],"prev_symbol":["HTT","OCD1"]},"alphafold":{"accession":"P31645","domains":[{"cath_id":"1.20.1740,1.20.1730","chopping":"104-214_222-620","consensus_level":"medium","plddt":94.1674,"start":104,"end":620}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P31645","model_url":"https://alphafold.ebi.ac.uk/files/AF-P31645-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P31645-F1-predicted_aligned_error_v6.png","plddt_mean":84.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=SLC6A4","jax_strain_url":"https://www.jax.org/strain/search?query=SLC6A4"},"sequence":{"accession":"P31645","fasta_url":"https://rest.uniprot.org/uniprotkb/P31645.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P31645/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P31645"}},"corpus_meta":[{"pmid":"12869766","id":"PMC_12869766","title":"Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene.","date":"2003","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/12869766","citation_count":4900,"is_preprint":false},{"pmid":"19015103","id":"PMC_19015103","title":"Oxytocin receptor (OXTR) and serotonin transporter (5-HTT) genes associated with observed parenting.","date":"2008","source":"Social cognitive and affective neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/19015103","citation_count":339,"is_preprint":false},{"pmid":"37032427","id":"PMC_37032427","title":"Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6, CYP2C19, CYP2B6, SLC6A4, and HTR2A Genotypes and Serotonin Reuptake Inhibitor Antidepressants.","date":"2023","source":"Clinical pharmacology and therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/37032427","citation_count":322,"is_preprint":false},{"pmid":"9361027","id":"PMC_9361027","title":"Serotonin transporter (5-HTT) gene variants associated with autism?","date":"1997","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9361027","citation_count":199,"is_preprint":false},{"pmid":"19215635","id":"PMC_19215635","title":"Early adversity and 5-HTT/BDNF genes: new evidence of gene-environment interactions on depressive symptoms in a general population.","date":"2009","source":"Psychological medicine","url":"https://pubmed.ncbi.nlm.nih.gov/19215635","citation_count":196,"is_preprint":false},{"pmid":"18347599","id":"PMC_18347599","title":"Evidence of biologic epistasis between BDNF and SLC6A4 and implications for depression.","date":"2008","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/18347599","citation_count":184,"is_preprint":false},{"pmid":"18824000","id":"PMC_18824000","title":"How the serotonin story is being rewritten by new gene-based discoveries principally related to SLC6A4, the serotonin transporter gene, which functions to influence all cellular serotonin systems.","date":"2008","source":"Neuropharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/18824000","citation_count":168,"is_preprint":false},{"pmid":"9672904","id":"PMC_9672904","title":"Evidence for linkage disequilibrium between serotonin transporter protein gene (SLC6A4) and obsessive compulsive disorder.","date":"1998","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/9672904","citation_count":151,"is_preprint":false},{"pmid":"16969368","id":"PMC_16969368","title":"Meta-analysis supports association between serotonin transporter (5-HTT) and suicidal behavior.","date":"2006","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/16969368","citation_count":129,"is_preprint":false},{"pmid":"17250964","id":"PMC_17250964","title":"Mechanical, thermal and formalin-induced nociception is differentially altered in 5-HT1A-/-, 5-HT1B-/-, 5-HT2A-/-, 5-HT3A-/- and 5-HTT-/- knock-out male mice.","date":"2007","source":"Pain","url":"https://pubmed.ncbi.nlm.nih.gov/17250964","citation_count":124,"is_preprint":false},{"pmid":"19487392","id":"PMC_19487392","title":"Serotonin transporter gene (SLC6A4) promoter polymorphisms and the susceptibility to posttraumatic stress disorder in the general population.","date":"2009","source":"The American journal of psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/19487392","citation_count":111,"is_preprint":false},{"pmid":"18618621","id":"PMC_18618621","title":"SLC6A4 variation and citalopram response.","date":"2009","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/18618621","citation_count":110,"is_preprint":false},{"pmid":"16205790","id":"PMC_16205790","title":"AVPR1a and SLC6A4 gene polymorphisms are associated with creative dance performance.","date":"2005","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16205790","citation_count":105,"is_preprint":false},{"pmid":"9514579","id":"PMC_9514579","title":"Serotonin transporter (5-HTT) gene polymorphisms are not associated with susceptibility to mood disorders.","date":"1998","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9514579","citation_count":105,"is_preprint":false},{"pmid":"17203304","id":"PMC_17203304","title":"Evidence for epistasis between SLC6A4 and ITGB3 in autism etiology and in the determination of platelet serotonin levels.","date":"2007","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17203304","citation_count":100,"is_preprint":false},{"pmid":"27565518","id":"PMC_27565518","title":"SLC6A4 methylation as an epigenetic marker of life adversity exposures in humans: A systematic review of literature.","date":"2016","source":"Neuroscience and biobehavioral reviews","url":"https://pubmed.ncbi.nlm.nih.gov/27565518","citation_count":95,"is_preprint":false},{"pmid":"21818344","id":"PMC_21818344","title":"Social defeat: impact on fear extinction and amygdala-prefrontal cortical theta synchrony in 5-HTT deficient mice.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21818344","citation_count":95,"is_preprint":false},{"pmid":"12911615","id":"PMC_12911615","title":"Glucocorticoid-regulated human serotonin transporter (5-HTT) expression is modulated by the 5-HTT gene-promotor-linked polymorphic region.","date":"2003","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/12911615","citation_count":94,"is_preprint":false},{"pmid":"15450911","id":"PMC_15450911","title":"Association studies of MAO-A, COMT, and 5-HTT genes polymorphisms in patients with anxiety disorders of the phobic spectrum.","date":"2004","source":"Psychiatry research","url":"https://pubmed.ncbi.nlm.nih.gov/15450911","citation_count":90,"is_preprint":false},{"pmid":"19249159","id":"PMC_19249159","title":"Sex-specific association between the 5-HTT gene-linked polymorphic region and basal cortisol secretion.","date":"2009","source":"Psychoneuroendocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/19249159","citation_count":88,"is_preprint":false},{"pmid":"18950748","id":"PMC_18950748","title":"Amygdala function and 5-HTT gene variants in adolescent anxiety and major depressive disorder.","date":"2008","source":"Biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/18950748","citation_count":85,"is_preprint":false},{"pmid":"18253134","id":"PMC_18253134","title":"Polymorphisms in the SLC6A4 and HTR2A genes influence treatment outcome following antidepressant therapy.","date":"2008","source":"The pharmacogenomics journal","url":"https://pubmed.ncbi.nlm.nih.gov/18253134","citation_count":79,"is_preprint":false},{"pmid":"21439906","id":"PMC_21439906","title":"Human serotonin transporter gene (SLC6A4) variants: their contributions to understanding pharmacogenomic and other functional G×G and G×E differences in health and disease.","date":"2011","source":"Current opinion in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21439906","citation_count":78,"is_preprint":false},{"pmid":"20406689","id":"PMC_20406689","title":"Serotonin transporter polymorphisms (SLC6A4 insertion/deletion and rs25531) do not affect the availability of 5-HTT to [11C] DASB binding in the living human brain.","date":"2010","source":"NeuroImage","url":"https://pubmed.ncbi.nlm.nih.gov/20406689","citation_count":76,"is_preprint":false},{"pmid":"19782704","id":"PMC_19782704","title":"Modulation of behavioural profile and stress response by 5-HTT genotype and social experience in adulthood.","date":"2009","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/19782704","citation_count":74,"is_preprint":false},{"pmid":"24657235","id":"PMC_24657235","title":"The potential of SLC6A4 gene methylation analysis for the diagnosis and treatment of major depression.","date":"2014","source":"Journal of psychiatric research","url":"https://pubmed.ncbi.nlm.nih.gov/24657235","citation_count":72,"is_preprint":false},{"pmid":"25825812","id":"PMC_25825812","title":"DNA methylation of the serotonin transporter gene (SLC6A4) is associated with brain function involved in processing emotional stimuli.","date":"2015","source":"Journal of psychiatry & neuroscience : JPN","url":"https://pubmed.ncbi.nlm.nih.gov/25825812","citation_count":68,"is_preprint":false},{"pmid":"20416884","id":"PMC_20416884","title":"Emotional eating in adolescents: a gene (SLC6A4/5-HTT) - depressive feelings interaction analysis.","date":"2010","source":"Journal of psychiatric research","url":"https://pubmed.ncbi.nlm.nih.gov/20416884","citation_count":66,"is_preprint":false},{"pmid":"23702251","id":"PMC_23702251","title":"A longitudinal study of SLC6A4 DNA promoter methylation and poststroke depression.","date":"2013","source":"Journal of psychiatric research","url":"https://pubmed.ncbi.nlm.nih.gov/23702251","citation_count":64,"is_preprint":false},{"pmid":"18663369","id":"PMC_18663369","title":"Panic disorder is associated with the serotonin transporter gene (SLC6A4) but not the promoter region (5-HTTLPR).","date":"2008","source":"Molecular psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/18663369","citation_count":63,"is_preprint":false},{"pmid":"30180828","id":"PMC_30180828","title":"Genotype-dependent associations between serotonin transporter gene (SLC6A4) DNA methylation and late-life depression.","date":"2018","source":"BMC psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/30180828","citation_count":62,"is_preprint":false},{"pmid":"19387615","id":"PMC_19387615","title":"5-HTT genotype effect on prefrontal-amygdala coupling differs between major depression and controls.","date":"2009","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/19387615","citation_count":57,"is_preprint":false},{"pmid":"9514585","id":"PMC_9514585","title":"Serotonin transporter (5-HTT) gene and bipolar affective disorder.","date":"1998","source":"American journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/9514585","citation_count":57,"is_preprint":false},{"pmid":"18495314","id":"PMC_18495314","title":"The effect of 5-HTT gene promoter polymorphism on impulsivity depends on family relations in girls.","date":"2008","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/18495314","citation_count":56,"is_preprint":false},{"pmid":"23428337","id":"PMC_23428337","title":"5-HTT and 5-HT(1A) receptor occupancy of the novel substance vortioxetine (Lu AA21004). A PET study in control subjects.","date":"2013","source":"European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/23428337","citation_count":55,"is_preprint":false},{"pmid":"20150867","id":"PMC_20150867","title":"The serotonin transporter gene (5-HTT) variant and psychiatric disorders: review of current literature.","date":"2010","source":"Neuro endocrinology letters","url":"https://pubmed.ncbi.nlm.nih.gov/20150867","citation_count":54,"is_preprint":false},{"pmid":"17564628","id":"PMC_17564628","title":"A genetic association study of 5-HTT LPR and GNbeta3 C825T polymorphisms with irritable bowel syndrome.","date":"2007","source":"Neurogastroenterology and motility","url":"https://pubmed.ncbi.nlm.nih.gov/17564628","citation_count":54,"is_preprint":false},{"pmid":"8925924","id":"PMC_8925924","title":"The membrane-bound rat serotonin transporter, SERT1, is an oligomeric protein.","date":"1996","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/8925924","citation_count":54,"is_preprint":false},{"pmid":"33344725","id":"PMC_33344725","title":"Increased methylation of NR3C1 and SLC6A4 is associated with blunted cortisol reactivity to stress in major depression.","date":"2020","source":"Neurobiology of stress","url":"https://pubmed.ncbi.nlm.nih.gov/33344725","citation_count":50,"is_preprint":false},{"pmid":"22457857","id":"PMC_22457857","title":"Serotonin transporter gene (SLC6A4) polymorphism in patients with irritable bowel syndrome and healthy controls.","date":"2012","source":"Journal of gastrointestinal and liver diseases : JGLD","url":"https://pubmed.ncbi.nlm.nih.gov/22457857","citation_count":48,"is_preprint":false},{"pmid":"27145764","id":"PMC_27145764","title":"Influence of 5-HTT variation, childhood trauma and self-efficacy on anxiety traits: a gene-environment-coping interaction study.","date":"2016","source":"Journal of neural transmission (Vienna, Austria : 1996)","url":"https://pubmed.ncbi.nlm.nih.gov/27145764","citation_count":47,"is_preprint":false},{"pmid":"31004120","id":"PMC_31004120","title":"5-HTT independent effects of fluoxetine on neuroplasticity.","date":"2019","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/31004120","citation_count":45,"is_preprint":false},{"pmid":"17124363","id":"PMC_17124363","title":"LEPR, ADBR3, IRS-1 and 5-HTT genes polymorphisms do not associate with obesity.","date":"2006","source":"Endocrine journal","url":"https://pubmed.ncbi.nlm.nih.gov/17124363","citation_count":45,"is_preprint":false},{"pmid":"24167611","id":"PMC_24167611","title":"5-HTT deficiency affects neuroplasticity and increases stress sensitivity resulting in altered spatial learning performance in the Morris water maze but not in the Barnes maze.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24167611","citation_count":45,"is_preprint":false},{"pmid":"16507957","id":"PMC_16507957","title":"Stressful life events, 5-HTT genotype and risk of depression.","date":"2006","source":"The British journal of psychiatry : the journal of mental science","url":"https://pubmed.ncbi.nlm.nih.gov/16507957","citation_count":44,"is_preprint":false},{"pmid":"19779024","id":"PMC_19779024","title":"Interaction of child maltreatment and 5-HTT polymorphisms: suicidal ideation among children from low-SES backgrounds.","date":"2009","source":"Journal of pediatric psychology","url":"https://pubmed.ncbi.nlm.nih.gov/19779024","citation_count":44,"is_preprint":false},{"pmid":"30529315","id":"PMC_30529315","title":"BDNF mediates the protective effects of scopolamine in reserpine-induced depression-like behaviors via up-regulation of 5-HTT and TPH1.","date":"2018","source":"Psychiatry research","url":"https://pubmed.ncbi.nlm.nih.gov/30529315","citation_count":41,"is_preprint":false},{"pmid":"22454241","id":"PMC_22454241","title":"Genetic polymorphisms of 5-HTT and DAT but not COMT differentially affect verbal and visuospatial working memory functioning.","date":"2012","source":"European archives of psychiatry and clinical neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/22454241","citation_count":40,"is_preprint":false},{"pmid":"19588468","id":"PMC_19588468","title":"Association and gene-gene interaction of SLC6A4 and ITGB3 in autism.","date":"2010","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19588468","citation_count":38,"is_preprint":false},{"pmid":"25335169","id":"PMC_25335169","title":"Prenatal stress-induced programming of genome-wide promoter DNA methylation in 5-HTT-deficient mice.","date":"2014","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/25335169","citation_count":38,"is_preprint":false},{"pmid":"26017091","id":"PMC_26017091","title":"Associations between serotonin transporter gene (SLC6A4) methylation and clinical characteristics and cortical thickness in children with ADHD.","date":"2015","source":"Psychological medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26017091","citation_count":38,"is_preprint":false},{"pmid":"23630162","id":"PMC_23630162","title":"Common and rare alleles of the serotonin transporter gene, SLC6A4, associated with Tourette's disorder.","date":"2013","source":"Movement disorders : official journal of the Movement Disorder Society","url":"https://pubmed.ncbi.nlm.nih.gov/23630162","citation_count":37,"is_preprint":false},{"pmid":"21750580","id":"PMC_21750580","title":"Presynaptic 5-HT1A is related to 5-HTT receptor density in the human brain.","date":"2011","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/21750580","citation_count":36,"is_preprint":false},{"pmid":"23518607","id":"PMC_23518607","title":"Multi-cultural association of the serotonin transporter gene (SLC6A4) with substance use disorder.","date":"2013","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/23518607","citation_count":36,"is_preprint":false},{"pmid":"16721604","id":"PMC_16721604","title":"ITGB3 shows genetic and expression interaction with SLC6A4.","date":"2006","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16721604","citation_count":35,"is_preprint":false},{"pmid":"24815315","id":"PMC_24815315","title":"Endotoxaemia resulting from decreased serotonin tranporter (5-HTT) function: a reciprocal risk factor for depression and insulin resistance?","date":"2014","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/24815315","citation_count":34,"is_preprint":false},{"pmid":"19118985","id":"PMC_19118985","title":"5-HT(1A) receptor and 5-HTT binding during the menstrual cycle in healthy women examined with [(11)C] WAY100635 and [(11)C] MADAM PET.","date":"2009","source":"Psychiatry research","url":"https://pubmed.ncbi.nlm.nih.gov/19118985","citation_count":34,"is_preprint":false},{"pmid":"17874074","id":"PMC_17874074","title":"A PET study on regional coexpression of 5-HT1A receptors and 5-HTT in the human brain.","date":"2007","source":"Psychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17874074","citation_count":34,"is_preprint":false},{"pmid":"25889020","id":"PMC_25889020","title":"Methylation of NR3C1 and SLC6A4 and internalizing problems. The TRAILS study.","date":"2015","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/25889020","citation_count":33,"is_preprint":false},{"pmid":"28821725","id":"PMC_28821725","title":"Interplay between maternal Slc6a4 mutation and prenatal stress: a possible mechanism for autistic behavior development.","date":"2017","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/28821725","citation_count":32,"is_preprint":false},{"pmid":"17291660","id":"PMC_17291660","title":"Association study of serotonin 2A receptor (5-HT2A) and serotonin transporter (5-HTT) gene polymorphisms with schizophrenia.","date":"2007","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/17291660","citation_count":32,"is_preprint":false},{"pmid":"17548158","id":"PMC_17548158","title":"Serotonin transporter gene (5-Htt): association analysis with temporal lobe epilepsy.","date":"2007","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/17548158","citation_count":31,"is_preprint":false},{"pmid":"20817074","id":"PMC_20817074","title":"Panic disorder and serotonergic genes (SLC6A4, HTR1A and HTR2A): Association and interaction with childhood trauma and parenting.","date":"2010","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/20817074","citation_count":30,"is_preprint":false},{"pmid":"21450309","id":"PMC_21450309","title":"Association of 5-HTT gene polymorphisms with migraine: a systematic review and meta-analysis.","date":"2011","source":"Journal of the neurological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/21450309","citation_count":29,"is_preprint":false},{"pmid":"28650965","id":"PMC_28650965","title":"Epigenetic adaptation of the placental serotonin transporter gene (SLC6A4) to gestational diabetes mellitus.","date":"2017","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/28650965","citation_count":29,"is_preprint":false},{"pmid":"25261775","id":"PMC_25261775","title":"SLC6A4 markers modulate platelet 5-HT level and specific behaviors of autism: a study from an Indian population.","date":"2014","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/25261775","citation_count":28,"is_preprint":false},{"pmid":"17766691","id":"PMC_17766691","title":"The long and the short of it: associations between 5-HTT genotypes and coping with stress.","date":"2007","source":"Psychosomatic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/17766691","citation_count":28,"is_preprint":false},{"pmid":"11900612","id":"PMC_11900612","title":"Serotonin transporter (5-HTT) gene polymorphisms and susceptibility to cocaine dependence among African-American individuals.","date":"2001","source":"Addiction biology","url":"https://pubmed.ncbi.nlm.nih.gov/11900612","citation_count":28,"is_preprint":false},{"pmid":"27381173","id":"PMC_27381173","title":"SLC6A4 promoter region methylation and socio-emotional stress response in very preterm and full-term infants.","date":"2016","source":"Epigenomics","url":"https://pubmed.ncbi.nlm.nih.gov/27381173","citation_count":27,"is_preprint":false},{"pmid":"36114180","id":"PMC_36114180","title":"Maternal and infant NR3C1 and SLC6A4 epigenetic signatures of the COVID-19 pandemic lockdown: when timing matters.","date":"2022","source":"Translational psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/36114180","citation_count":25,"is_preprint":false},{"pmid":"26261165","id":"PMC_26261165","title":"Association of serotonin transporter (SLC6A4) and receptor (5HTR1A, 5HTR2A) polymorphisms with response to treatment with escitalopram in patients with major depressive disorder: A preliminary study.","date":"2015","source":"The Indian journal of medical research","url":"https://pubmed.ncbi.nlm.nih.gov/26261165","citation_count":25,"is_preprint":false},{"pmid":"21647174","id":"PMC_21647174","title":"Berberine and evodiamine influence serotonin transporter (5-HTT) expression via the 5-HTT-linked polymorphic region.","date":"2011","source":"The pharmacogenomics journal","url":"https://pubmed.ncbi.nlm.nih.gov/21647174","citation_count":25,"is_preprint":false},{"pmid":"22855291","id":"PMC_22855291","title":"The role of 5-HTT LPR and GNβ3 825C>T polymorphisms and gene-environment interactions in irritable bowel syndrome (IBS).","date":"2012","source":"Digestive diseases and sciences","url":"https://pubmed.ncbi.nlm.nih.gov/22855291","citation_count":24,"is_preprint":false},{"pmid":"25927430","id":"PMC_25927430","title":"Association of DRD3, COMT, and SLC6A4 Gene Polymorphisms with Type 2 Diabetes in Southern Chinese: A Hospital-Based Case-Control Study.","date":"2015","source":"Diabetes technology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/25927430","citation_count":23,"is_preprint":false},{"pmid":"24385047","id":"PMC_24385047","title":"SLC6A4 polymorphism, population genetics, and psychiatric traits.","date":"2014","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24385047","citation_count":22,"is_preprint":false},{"pmid":"30622309","id":"PMC_30622309","title":"Differential SLC6A4 methylation: a predictive epigenetic marker of adiposity from birth to adulthood.","date":"2019","source":"International journal of obesity (2005)","url":"https://pubmed.ncbi.nlm.nih.gov/30622309","citation_count":22,"is_preprint":false},{"pmid":"19824018","id":"PMC_19824018","title":"Relevance of perceived childhood neglect, 5-HTT gene variants and hypothalamus-pituitary-adrenal axis dysregulation to substance abuse susceptibility.","date":"2010","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19824018","citation_count":22,"is_preprint":false},{"pmid":"24069428","id":"PMC_24069428","title":"A serotonin transporter gene (SLC6A4) polymorphism is associated with reduced risk of irritable bowel syndrome in American and Asian population: a meta-analysis.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24069428","citation_count":21,"is_preprint":false},{"pmid":"20653450","id":"PMC_20653450","title":"Gene-gene interaction between serotonin transporter (SLC6A4) and CLOCK modulates the risk of metabolic syndrome in rotating shiftworkers.","date":"2010","source":"Chronobiology international","url":"https://pubmed.ncbi.nlm.nih.gov/20653450","citation_count":21,"is_preprint":false},{"pmid":"23583772","id":"PMC_23583772","title":"Association of serotonin transporter gene (SLC6A4) polymorphisms with schizophrenia susceptibility and symptoms in a Chinese-Han population.","date":"2013","source":"Progress in neuro-psychopharmacology & biological psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/23583772","citation_count":21,"is_preprint":false},{"pmid":"30218748","id":"PMC_30218748","title":"5-HTT, BMPR2, EDN1, ENG, KCNA5 gene polymorphisms and susceptibility to pulmonary arterial hypertension: A meta-analysis.","date":"2018","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/30218748","citation_count":20,"is_preprint":false},{"pmid":"23635830","id":"PMC_23635830","title":"Serotonergic genes (5-HTT and HTR1A) and separation life events: gene-by-environment interaction for panic disorder.","date":"2013","source":"Neuropsychobiology","url":"https://pubmed.ncbi.nlm.nih.gov/23635830","citation_count":20,"is_preprint":false},{"pmid":"27176146","id":"PMC_27176146","title":"Correlation of 5-HTT, BDNF and NPSR1 gene polymorphisms with anxiety and depression in asthmatic patients.","date":"2016","source":"International journal of molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/27176146","citation_count":20,"is_preprint":false},{"pmid":"29331882","id":"PMC_29331882","title":"Association analysis of SLC6A4 and HTR2A genes with obsessive-compulsive disorder: Influence of the STin2 polymorphism.","date":"2017","source":"Comprehensive psychiatry","url":"https://pubmed.ncbi.nlm.nih.gov/29331882","citation_count":20,"is_preprint":false},{"pmid":"30447571","id":"PMC_30447571","title":"Epigenetic variation at the SLC6A4 gene promoter in mother-child pairs with major depressive disorder.","date":"2018","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/30447571","citation_count":20,"is_preprint":false},{"pmid":"17299512","id":"PMC_17299512","title":"Monoamine metabolites level in CSF is related to the 5-HTT gene polymorphism in treatment-resistant depression.","date":"2007","source":"Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/17299512","citation_count":20,"is_preprint":false},{"pmid":"21982504","id":"PMC_21982504","title":"Stressful life events and the serotonin transporter gene (5-HTT) in recurrent clinical depression.","date":"2011","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/21982504","citation_count":20,"is_preprint":false},{"pmid":"24392134","id":"PMC_24392134","title":"Association study of serotonin transporter SLC6A4 gene with Chinese Han irritable bowel syndrome.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24392134","citation_count":20,"is_preprint":false},{"pmid":"24755731","id":"PMC_24755731","title":"The association of 5-HT2A, 5-HTT, and LEPR polymorphisms with obstructive sleep apnea syndrome: a systematic review and meta-analysis.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24755731","citation_count":19,"is_preprint":false},{"pmid":"26544069","id":"PMC_26544069","title":"Effect of Simvastatin on 5-HT and 5-HTT in a Rat Model of Pulmonary Artery Hypertension.","date":"2015","source":"Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/26544069","citation_count":19,"is_preprint":false},{"pmid":"34509065","id":"PMC_34509065","title":"Role of NR3C1 and SLC6A4 methylation in the HPA axis regulation in burnout.","date":"2021","source":"Journal of affective disorders","url":"https://pubmed.ncbi.nlm.nih.gov/34509065","citation_count":19,"is_preprint":false},{"pmid":"32256307","id":"PMC_32256307","title":"Amygdala 5-HTT Gene Network Moderates the Effects of Postnatal Adversity on Attention Problems: Anatomo-Functional Correlation and Epigenetic Changes.","date":"2020","source":"Frontiers in neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/32256307","citation_count":19,"is_preprint":false},{"pmid":"29313869","id":"PMC_29313869","title":"Negative social acts and pain: evidence of a workplace bullying and 5-HTT genotype interaction.","date":"2018","source":"Scandinavian journal of work, environment & health","url":"https://pubmed.ncbi.nlm.nih.gov/29313869","citation_count":19,"is_preprint":false},{"pmid":"30643413","id":"PMC_30643413","title":"Association between the SLC6A4 gene and schizophrenia: an updated meta-analysis.","date":"2018","source":"Neuropsychiatric disease and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/30643413","citation_count":18,"is_preprint":false},{"pmid":"37852405","id":"PMC_37852405","title":"Serotonin Transporter (5-Hydroxytryptamine Transporter, SERT, SLC6A4) and Sodium-dependent Reuptake Inhibitors as Modulators of Pain Behaviors and Analgesic Responses.","date":"2023","source":"The journal of pain","url":"https://pubmed.ncbi.nlm.nih.gov/37852405","citation_count":18,"is_preprint":false},{"pmid":"35066124","id":"PMC_35066124","title":"5-Hydroxytryptamine activates a 5-HT/c-Myc/SLC6A4 signaling loop in non-small cell lung cancer.","date":"2022","source":"Biochimica et biophysica acta. General subjects","url":"https://pubmed.ncbi.nlm.nih.gov/35066124","citation_count":17,"is_preprint":false},{"pmid":"25522398","id":"PMC_25522398","title":"5-HT2C receptor desensitization moderates anxiety in 5-HTT deficient mice: from behavioral to cellular evidence.","date":"2014","source":"The international journal of neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/25522398","citation_count":17,"is_preprint":false},{"pmid":"22384070","id":"PMC_22384070","title":"AVPR1A and SLC6A4 polymorphisms in choral singers and non-musicians: a gene association study.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22384070","citation_count":17,"is_preprint":false},{"pmid":"24229495","id":"PMC_24229495","title":"Gender-specific association of the SLC6A4 and DRD2 gene variants in bipolar disorder.","date":"2013","source":"The international journal of neuropsychopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/24229495","citation_count":17,"is_preprint":false},{"pmid":"20002020","id":"PMC_20002020","title":"Interaction of SLC6A4 and DRD2 polymorphisms is associated with a history of delirium tremens.","date":"2010","source":"Addiction biology","url":"https://pubmed.ncbi.nlm.nih.gov/20002020","citation_count":17,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":54776,"output_tokens":2974,"usd":0.104469,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":10364,"output_tokens":3418,"usd":0.068635,"stage2_stop_reason":"end_turn"},"total_usd":0.173104,"stage1_batch_id":"msgbatch_013LWZZT6MWaqB9qyTSeQBmU","stage2_batch_id":"msgbatch_0194ZzQaTGNpruoNJBbEMbt3","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1996,\n      \"finding\": \"The rat serotonin transporter SERT1 (SLC6A4 ortholog) forms oligomeric complexes at the membrane. Treatment of recombinantly expressed SERT1 in HEK293 cells with sulfhydryl oxidizing agents and the cross-linker dimethyl suberimidate (DMS) generated adducts of 130–180 kDa and 220–270 kDa, indicating an oligomeric (likely dimeric/tetrameric) quaternary structure.\",\n      \"method\": \"Chemical cross-linking (DMS), sulfhydryl oxidation, SDS-PAGE of recombinantly expressed SERT1 in HEK293 cells\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — in vitro biochemical reconstitution with cross-linking in a single study; no mutagenesis or structural validation to define interface\",\n      \"pmids\": [\"8925924\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2003,\n      \"finding\": \"Glucocorticoid (dexamethasone) administration increases SLC6A4 (5-HTT) expression in a genotype-dependent manner in human B-lymphoblastoid cells. Reporter gene assays, 5-HT uptake, and inhibitor binding measures showed a dose-response to dexamethasone that was antagonized by RU 38486, and depended on a repetitive GC-rich sequence ~1.4 kb upstream of the transcription start site (within the 5-HTTLPR region), as deletion of this sequence abolished the steroid effect.\",\n      \"method\": \"Reporter gene (luciferase) assays, 5-HT uptake assay, radioligand binding, deletional mutagenesis of promoter constructs, pharmacological antagonism (RU 38486) in human lymphoblastoid cells\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — multiple orthogonal methods (reporter assay, uptake, binding, deletional mutagenesis, pharmacological rescue) in a single well-controlled study\",\n      \"pmids\": [\"12911615\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Berberine and evodiamine increase SLC6A4 (5-HTT) mRNA and protein expression, and increase 5-HTT promoter activity in a serotonergic neuronal cell line (RN46A). The magnitude of the promoter activity increase was allele-specific across S, XS, LG, LA, XL17, and XL18 variants of the 5-HTTLPR, demonstrating that the 5-HTTLPR polymorphism modulates the transcriptional response to these compounds.\",\n      \"method\": \"RT-PCR (mRNA), Western blot (protein), luciferase reporter assays across multiple allelic variants in RN46A cells\",\n      \"journal\": \"The pharmacogenomics journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 / Weak — multiple methods (mRNA, protein, reporter) in a single lab; no in vivo validation or independent replication\",\n      \"pmids\": [\"21647174\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Fluoxetine activates BDNF/TrkB signaling and promotes neuroplasticity through a 5-HTT-independent mechanism. In primary cortical neurons from 5-Htt knockout mice, fluoxetine (10 µM) still activated BDNF/TrkB pathways and increased plasticity gene expression, demonstrating that 5-HTT blockade is not required for these neuroplastic effects of fluoxetine.\",\n      \"method\": \"Western blotting, RT-qPCR in primary cortical neurons from 5-Htt wild-type and knockout mice; in vivo treatment (15 mg/kg/day i.p.) with assessment of hippocampal cell proliferation\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic KO model with multiple molecular readouts (protein, mRNA, proliferation); single lab but orthogonal methods\",\n      \"pmids\": [\"31004120\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Loss of 5-HTT (SLC6A4) in mice impairs extinction recall of conditioned fear and is accompanied by increased theta synchronization between the lateral amygdala and infralimbic prefrontal cortex during extinction learning, establishing a role for 5-HTT in amygdala-prefrontal circuit function underlying fear extinction.\",\n      \"method\": \"Pavlovian fear conditioning, in vivo electrophysiology (simultaneous recording in lateral amygdala and mPFC), behavioral testing in 5-HTT knockout (-/-), heterozygous (+/-), and wild-type (+/+) mice\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — clean genetic KO with paired behavioral and neurophysiological readouts; single lab, multiple orthogonal measures\",\n      \"pmids\": [\"21818344\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"5-HTT deficiency in mice increases hippocampal adult neurogenesis (elevated Ki67+ and NeuroD+ cell counts) and immediate early gene expression (cFos, Arc), and heightens corticosterone responses to spatial learning tasks, establishing that SLC6A4 regulates hippocampal neuroplasticity and stress reactivity in vivo.\",\n      \"method\": \"Quantitative immunohistochemistry (Ki67, NeuroD, cFos, Arc), plasma corticosterone measurement, Morris water maze and Barnes maze behavioral testing in 5-HTT knockout and wild-type mice\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with multiple cellular and behavioral readouts; single lab study\",\n      \"pmids\": [\"24167611\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"5-HT2C receptor responsiveness is blunted in 5-HTT-deficient mice: 5-HTT(-/-) mice show reduced 5-HT2CR-mediated anxiety behavior and attenuated 5-HT2CR-mediated inhibition of stress-induced 5-HT turnover, without changes in 5-HT2CR protein, mRNA levels, or pre-mRNA editing. However, basal c-fos mRNA in 5-HT2CR-expressing cortical cells was elevated in knockouts, indicating altered basal cellular activity downstream of chronic 5-HT reuptake inactivation.\",\n      \"method\": \"Behavioral tests (social interaction, novelty-suppressed feeding, hypolocomotion), neurochemical assays (5-HT turnover), RT-qPCR, mRNA editing analysis, c-fos immunohistochemistry in 5-HTT(-/-) mice\",\n      \"journal\": \"The international journal of neuropsychopharmacology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic KO with multiple orthogonal readouts (behavioral, neurochemical, molecular); single lab\",\n      \"pmids\": [\"25522398\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In non-small cell lung cancer (NSCLC) cells, 5-HT promotes SLC6A4 expression via a c-Myc/TRIB3-dependent signaling loop: 5-HT activates TRIB3, which stimulates c-Myc transcriptional activity, and c-Myc upregulates SLC6A4 expression, thereby enhancing 5-HT uptake into tumor cells and creating a positive feedback loop that promotes tumorigenicity and metastasis.\",\n      \"method\": \"Western blotting, immunofluorescence, colony-formation assay, Transwell migration/invasion assay, immunohistochemistry in NSCLC patient tissues and A549 cells; in vivo xenograft model with 5-HT uptake inhibitor\",\n      \"journal\": \"Biochimica et biophysica acta. General subjects\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — multiple orthogonal methods (molecular, cellular, in vivo) identifying a mechanistic loop; single lab study\",\n      \"pmids\": [\"35066124\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"DNA methylation of the SLC6A4 distal promoter region inversely correlates with SLC6A4 mRNA expression in human placenta, and gestational diabetes mellitus decreases average methylation at this region, suggesting epigenetic regulation of placental SLC6A4 expression by maternal metabolic state. No significant association was found between SLC6A4 genotype (5-HTTLPR, STin2, rs25531) and placental mRNA levels, indicating a predominant epigenetic over genetic regulation of expression in this tissue.\",\n      \"method\": \"Bisulfite sequencing (quantitative CpG methylation at 7 sites), RT-qPCR (mRNA expression), PCR-based genotyping in human placental tissue from 50 mother-infant pairs\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct methylation-expression correlation in human tissue with orthogonal methods; single study, modest sample size\",\n      \"pmids\": [\"28650965\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PET imaging with [11C]DASB in 63 healthy volunteers showed that 5-HTTLPR polymorphic variation (biallelic S/L or triallelic LA/LG/S classification) does not significantly affect 5-HTT binding potential in any of seven brain regions in vivo, suggesting that reported effects of 5-HTTLPR on emotion and depression risk are more likely mediated through neurodevelopmental effects rather than adult transporter density differences.\",\n      \"method\": \"Positron emission tomography (PET) with [11C]DASB radioligand, binding potential quantification in seven brain regions, genotyping for 5-HTTLPR and rs25531\",\n      \"journal\": \"NeuroImage\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — rigorous PET imaging in a relatively large sample (n=63) with optimal radiotracer; single study but well-controlled negative finding\",\n      \"pmids\": [\"20406689\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"SLC6A4 encodes the serotonin transporter (SERT/5-HTT), a sodium-dependent membrane protein that reuptakes serotonin from the synapse into presynaptic neurons; it forms oligomeric complexes, its transcription is upregulated by glucocorticoids through a GC-rich upstream element in an allele-specific manner, its promoter is subject to DNA methylation that inversely correlates with expression, it regulates hippocampal neuroplasticity and amygdala-prefrontal circuit function underlying fear extinction, modulates 5-HT2C receptor responsiveness through chronic serotonin exposure, and in cancer cells participates in a c-Myc/TRIB3-driven positive feedback loop that promotes 5-HT uptake and tumor progression.\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"SLC6A4 encodes the serotonin transporter (SERT/5-HTT), a sodium-dependent membrane transporter that clears serotonin (5-HT) from the extracellular space and assembles into oligomeric (dimeric/tetrameric) complexes at the membrane [#0, #7]. Its transcription is under combined hormonal and epigenetic control: glucocorticoids upregulate expression through a GC-rich element ~1.4 kb upstream of the start site within the 5-HTTLPR region in a genotype-dependent, RU 38486–reversible manner [#1], small-molecule inducers (berberine, evodiamine) drive promoter activity in an allele-specific fashion across 5-HTTLPR variants [#2], and DNA methylation of the distal promoter inversely tracks with mRNA levels in human tissue [#8]. In vivo, loss of 5-HTT shapes neural circuit function and plasticity: knockout mice show impaired fear extinction recall with altered amygdala–prefrontal theta synchronization [#4], increased hippocampal adult neurogenesis and immediate-early gene expression with heightened corticosterone stress responses [#5], and blunted 5-HT2C receptor–mediated behavioral and neurochemical responses downstream of chronic loss of 5-HT reuptake [#6]. Beyond the nervous system, SLC6A4 participates in a c-Myc/TRIB3-driven positive feedback loop in non-small cell lung cancer in which 5-HT induces its own transporter, enhancing 5-HT uptake to promote tumorigenicity and metastasis [#7]. Notably, some neuroplastic effects of fluoxetine occur independently of 5-HTT, as fluoxetine still activates BDNF/TrkB signaling in 5-HTT-knockout neurons [#3].\",\n  \"teleology\": [\n    {\n      \"year\": 1996,\n      \"claim\": \"Established that SERT is not an isolated monomer but assembles into higher-order oligomers at the membrane, defining its quaternary structure.\",\n      \"evidence\": \"Chemical cross-linking (DMS) and sulfhydryl oxidation of recombinant rat SERT1 in HEK293 cells resolved by SDS-PAGE\",\n      \"pmids\": [\"8925924\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"No mutagenesis or structural data defining the oligomerization interface\", \"Functional consequence of oligomerization for transport not addressed\", \"Demonstrated for rat ortholog in heterologous cells only\"]\n    },\n    {\n      \"year\": 2003,\n      \"claim\": \"Resolved how stress hormones control transporter abundance, showing glucocorticoid induction of SLC6A4 operates through a defined upstream GC-rich element in a genotype-dependent way.\",\n      \"evidence\": \"Reporter assays, 5-HT uptake, radioligand binding, promoter deletional mutagenesis and RU 38486 antagonism in human lymphoblastoid cells\",\n      \"pmids\": [\"12911615\"],\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Whether the same element governs glucocorticoid regulation in neurons not tested\", \"Direct receptor binding to the element not demonstrated\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Tested whether the 5-HTTLPR genotype alters transporter density in the living human brain, and found no significant effect, redirecting interpretation toward neurodevelopmental rather than adult-density mechanisms.\",\n      \"evidence\": \"PET with [11C]DASB binding potential across seven brain regions in 63 genotyped healthy volunteers\",\n      \"pmids\": [\"20406689\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Negative finding in adults does not exclude developmental or regional micro-scale effects\", \"Does not address functional (uptake kinetics) differences independent of density\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Connected 5-HTT loss to a specific behavioral circuit, showing it is required for fear extinction recall and normal amygdala-prefrontal oscillatory coupling.\",\n      \"evidence\": \"Pavlovian fear conditioning with paired in vivo electrophysiology in 5-HTT knockout, heterozygous, and wild-type mice\",\n      \"pmids\": [\"21818344\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Developmental vs acute contribution of 5-HTT loss not separated\", \"Cell-type and circuit-specific mediators of theta change unresolved\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Showed that the transcriptional response of SLC6A4 to pharmacological inducers is shaped by 5-HTTLPR allelic identity, extending allele-specific regulation beyond glucocorticoids.\",\n      \"evidence\": \"RT-PCR, Western blot, and luciferase reporter assays across S, XS, LG, LA, XL17, XL18 variants in RN46A serotonergic cells\",\n      \"pmids\": [\"21647174\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"No in vivo validation\", \"Mechanism linking compounds to promoter not defined\", \"Not independently replicated\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrated that chronic loss of reuptake reshapes hippocampal plasticity and stress reactivity, establishing a role for SLC6A4 in neurogenesis and corticosterone responses.\",\n      \"evidence\": \"Quantitative immunohistochemistry (Ki67, NeuroD, cFos, Arc), plasma corticosterone, and maze behavioral testing in 5-HTT knockout mice\",\n      \"pmids\": [\"24167611\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Whether plasticity changes are cause or consequence of altered behavior unclear\", \"Single-lab study\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified a downstream consequence of chronic reuptake loss on receptor signaling, showing blunted 5-HT2C receptor responsiveness without changes in receptor expression or editing.\",\n      \"evidence\": \"Behavioral, neurochemical (5-HT turnover), RT-qPCR, mRNA editing, and c-fos IHC analyses in 5-HTT knockout mice\",\n      \"pmids\": [\"25522398\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Mechanism of functional 5-HT2C desensitization not defined\", \"Elevated basal c-fos not mechanistically explained\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Established epigenetic control of SLC6A4 expression in a peripheral tissue, showing distal-promoter methylation inversely tracks mRNA and is modulated by maternal metabolic state.\",\n      \"evidence\": \"Bisulfite sequencing, RT-qPCR, and genotyping in human placenta from 50 mother-infant pairs\",\n      \"pmids\": [\"28650965\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Causality of methylation on expression not demonstrated\", \"Modest sample size\", \"Tissue-specificity vs neuronal regulation unaddressed\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Dissociated fluoxetine's neuroplastic action from its target, showing BDNF/TrkB activation persists without 5-HTT.\",\n      \"evidence\": \"Western blotting and RT-qPCR in primary cortical neurons from 5-Htt knockout and wild-type mice, with in vivo proliferation assessment\",\n      \"pmids\": [\"31004120\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Alternative direct fluoxetine target not identified\", \"Relevance to therapeutic antidepressant action not established\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Extended SLC6A4 function beyond neurons, defining a c-Myc/TRIB3 positive feedback loop in which 5-HT induces its own transporter to drive tumor progression.\",\n      \"evidence\": \"Western blot, immunofluorescence, colony-formation, migration/invasion assays, patient IHC, and xenograft with uptake inhibitor in NSCLC cells\",\n      \"pmids\": [\"35066124\"],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"Direct c-Myc binding to the SLC6A4 promoter not shown\", \"Generalizability to other tumor types untested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How transporter oligomerization, allele- and methylation-dependent transcriptional control, and circuit-level neuroplasticity phenotypes mechanistically interconnect remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"\",\n      \"gaps\": [\"No structural model linking oligomerization to transport function in the captured corpus\", \"Causal chain from transcriptional/epigenetic regulation to in vivo behavioral phenotypes not established\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0005215\", \"supporting_discovery_ids\": [1, 7]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [0]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"GO:0112316\", \"supporting_discovery_ids\": [4]}\n    ],\n    \"complexes\": [],\n    \"partners\": [],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":5,"faith_total":5,"faith_pct":100.0}}